Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
View Patent ↗Single vector constructs for expression of a functional antibody molecule are described. The vectors have a self-processing cleavage site between two heterologous DNA coding sequences allowing for expression of two coding sequences using a single promoter. Exemplary vector constructs comprise a foot and mouth disease virus (FMDV) 2A sequence. The vector constructs can be used in methods relating to antibody delivery and therapy and in the production of a biologically active antibody or fragment thereof.
1. An adeno-associated virus (AAV) vector for expression of a recombinant antibody or a recombinant antibody fragment having antigen-binding activity, wherein the antibody fragment is selected from the group consisting of Fab, F(ab′) 2 and Fv(scFv) antibody fragments, the vector comprising in the 5′ to 3′ direction: a promoter operably linked to all of (1) a coding sequence for a heavy chain of the antibody or a fragment of the heavy chain, (2) a sequence encoding a furin proteolytic cleavage site, (3) a sequence encoding a 2A self-processing cleavage site and (4) a coding sequence for a light chain of the antibody or a fragment of the light chain.
2. The vector according to claim 1 , wherein the 2A self-processing cleavage site is SEQ ID NO: 1.
3. The vector according to claim 1 , wherein the coding sequence for the heavy chain of the antibody is the full length coding sequence.
4. The vector according to claim 1 , wherein the coding sequence for the light chain of the antibody is the full length coding sequence.
5. The vector according to claim 1 , wherein the 2A self-processing cleavage site is SEQ ID NO: 5.
6. The expression vector according to claim 5 , wherein the promoter is selected from the group consisting of an elongation factor 1-alpha promoter (EF1α) promoter, a phosphoglycerate kinase-1 promoter (PGK) promoter, a cytomegalovirus immediate early gene promoter (CMV), a chimeric liver-specific promoter (LSP), a cytomegalovirus enhancer/chicken beta-actin promoter (CAG), a tetracycline responsive promoter (TRE), a transthyretin promoter (TTR), a simiun virus 40 promoter (SV40) and a CK6 promoter.
7. The vector according to claim 6 , wherein said promoter is the CAG promoter.
8. An isolated host cell transfected with the vector of claim 7 .
9. An isolated host cell transfected with the vector of claim 5 .
10. The vector according to claim 1 , further comprising a signal sequence 5′ to the coding sequence for the heavy chain of the antibody or the fragment of the heavy chain, or the coding sequence for the light chain of the antibody or the fragment of the light chain.
11. The vector according to claim 1 , wherein the promoter is selected from the group consisting of an elongation factor 1-alpha promoter (EF1α) promoter, a phosphoglycerate kinase-1 promoter (PGK) promoter, a cytomegalovirus immediate early gene promoter (CMV), a chimeric liver-specific promoter (LSP), a cytomegalovirus enhancer/chicken beta-actin promoter (CAG), a tetracycline responsive promoter (TRE), a transthyretin promoter (TTR), a simian virus 40 promoter (SV40) and a CK6 promoter.
12. The vector according to claim 1 , wherein the sequence encoding the furin cleavage site encodes an oligopeptide with the consensus sequence RXK(R)R (SEQ ID NO: 12).
13. An isolated host cell transfected with the vector of claim 12 .
14. The vector according to claim 1 , wherein the 2A self-processing cleavage site is SEQ ID NO: 8.
15. An adeno-associated virus (AAV) vector for the expression of a recombinant antibody or a recombinant antibody fragment having antigen-binding activity, wherein the recombinant antibody fragment is selected from the group consisting of Fab, F(ab′) 2 and Fv(scFv) antibody fragments, the vector comprising in the 5′ to 3′ direction: a promoter operably linked to all of (1) a coding sequence for a heavy chain of the antibody or a fragment of the heavy chain, (2) a sequence encoding a furin cleavage site, (3) a sequence encoding a 2A self-processing cleavage site and (4) a coding sequence for a light chain of the antibody or a fragment of the light chain, wherein the 2A self-processing cleavage site is selected from the group consisting of the sequences presented as SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8, and wherein the heavy chain of the antibody or the fragment of the heavy chain and the light chain of the antibody or the fragment of the light chain are expressed in an equimolar ratio.
16. The vector according to claim 15 , wherein the 2A self-processing cleavage site is SEQ ID NO: 1.
17. The vector according to claim 15 , wherein the coding sequence of the heavy chain of the antibody is the full length coding sequence.
18. The vector according to claim 15 , further comprising a signal sequence 5′ to the coding sequence for the heavy chain of the antibody or the fragment of the heavy chain, or the coding sequence for the light chain of the antibody or the fragment of the light chain.
19. The vector according to claim 15 , wherein the sequence encoding the furin cleavage site encodes an oligopeptide with the consensus sequence RXK(R)R (SEQ ID NO: 12).
20. An isolated host cell transfected with the vector of claim 19 .